ALLMedicine™ Creutzfeldt-jakob Disease Center
Research & Reviews 721 results
https://doi.org/10.2217/nmt-2021-0025
Neurodegenerative Disease Management; Tayyebi G, Malakouti SK et. al.
Dec 3rd, 2021 - Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care ...
https://doi.org/10.1007/s00330-021-08363-1 10.1016/S1473-3099(19)30615-2 10.1093/brain/awm063 10.1093/brain/awh249 10.1001/jamaneurol.2015.4885 10.1148/rg.2017160075 10.1212/01.WNL.0000134555.59460.5D 10.1111/jon.12098 10.1159/000445768 10.1001/jamaneurol.2015.3159 10.1097/WAD.0b013e31818323ef 10.1007/s00415-015-7723-6 10.1007/s10072-008-0976-4 10.1136/jnnp-2020-323826 10.1093/brain/awp191 10.1002/sim.2427 10.1016/S0895-4356(01)00341-9 10.1007/s002340100695 10.1016/j.ijge.2011.09.007 10.3348/kjr.2018.0615 10.1148/radiol.2492071681
European Radiology; Park HY, Suh CH et. al.
Nov 30th, 2021 - To evaluate clinico-radiologic markers that predict poor overall survival (OS) in sporadic Creutzfeldt-Jakob disease (sCJD) and to develop a prognostic model. Patients with newly diagnosed sCJD were included who underwent diffusion-weighted imagin...
https://doi.org/10.1186/s40478-021-01286-4 10.1212/wnl.46.4.1123 10.1136/jnnp-2018-319221 10.1099/0022-1317-78-5-1187 10.1099/0022-1317-77-8-1925 10.1099/0022-1317-79-3-601 10.1038/nn.2483 10.1038/39057 10.1126/science.1190815 10.1212/WNL.48.3.784 10.1007/s004010051108 10.1038/nm922 10.1007/s004010051109 10.1016/S0140-6736(98)12075-5 10.1016/S0140-6736(97)24002-X 10.1016/S0140-6736(98)24035-9 10.1099/vir.0.82186-0 10.1093/infdis/jiv232 10.1136/jnnp.2003.035154 10.1053/jcpa.2001.0476 10.1099/0022-1317-68-7-1875 10.1038/s41374-021-00641-2 10.1097/01.jnen.0000175330.66715.08 10.1126/science.1183218 10.1128/JVI.75.19.9320-9327.2001 10.1002/mus.880151103 10.1001/archneur.59.9.1430 10.1212/WNL.52.9.1757 10.1002/ana.410390613 10.1007/s00401-009-0585-1 10.1126/science.6801762 10.1016/S0002-9440(10)64705-0 10.1371/journal.ppat.1006298 10.1371/journal.pone.0117063 10.3201/eid1709.101403 10.1051/vetres:2007061 10.1212/NXI.0000000000000173 10.2353/ajpath.2009.090623 10.3389/fnagi.2017.00187 10.1002/ana.410430611 10.1016/S0140-6736(96)91412-9 10.1007/s00415-009-0037-9
Acta Neuropathologica Communications; Hofmann A, Wrede A et. al.
Nov 26th, 2021 - In sporadic Creutzfeldt-Jakob disease (sCJD), the pathological changes appear to be restricted to the central nervous system. Only involvement of the trigeminal ganglion is widely accepted. The present study systematically examined the involvement...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593757
BMJ Open; Shi Q, Xiao K et. al.
Nov 17th, 2021 - Two different mutations at codon 196, namely E196A and E196K, have been reported to be related to genetic Creutzfeldt-Jakob disease (CJD). We aimed to comparatively analyse the features of Chinese patients with these two mutations from the CJD sur...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583147
Prion de Melo ASLF, Lima JLD et. al.
Nov 10th, 2021 - Creutzfeldt-Jakob disease (CJD) is a rare and fatal condition that leads to progressive neurodegeneration due to gliosis, vacuolation of central nervous system tissue, and loss of neurons. Microglia play a crucial role in maintaining Central Nervo...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT00104663
Apr 7th, 2015 - The human prion diseases have been traditionally classified into Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker (GSS) disease and kuru. They can alternatively be classified into three causal categories: sporadic, acquired and inhe...
News 65 results
https://www.staging.medscape.com/viewarticle/935529
Aug 12th, 2020 - NEW YORK (Reuters Health) - Preclinical studies suggest that prion-protein reduction may provide therapeutic benefit in prion diseases, according to a multinational group of researchers. "Our study shows in several different ways that in rodent mo...
https://www.staging.medscape.com/viewarticle/932068
Jun 10th, 2020 - Recommendations from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) on the use of convalescent plasma to treat COVID-19 have been published, ahead of planned clinical trials to commence this month. SaBTO said it is satis...
https://www.medscape.com/viewarticle/932068
Jun 10th, 2020 - Recommendations from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) on the use of convalescent plasma to treat COVID-19 have been published, ahead of planned clinical trials to commence this month. SaBTO said it is satis...
https://reference.medscape.com/viewarticle/912046_2
May 23rd, 2019 - Answer 1/5 Memory-sparing can be observed with which of the following in the early stages of dementia? Your peers chose: Alzheimer disease and frontotemporal dementia (FTD) 0% Chronic traumatic encephalopathy (CTE) and FTD 0% Dementia with Lewy bo...
https://www.mdedge.com/neurology/article/200209/rare-diseases/csf-and-plasma-biomarkers-predict-survival-sporadic/page/0/1?channel=27970
May 6th, 2019 - Plasma total tau was associated with survival In all, 188 patients were included in the analysis. The population’s mean age was 63.
